HK1157821A1 - -/ 檢測尿的間皮素/巨核細胞促進因子相關肽用於評估卵巢癌 - Google Patents

-/ 檢測尿的間皮素/巨核細胞促進因子相關肽用於評估卵巢癌

Info

Publication number
HK1157821A1
HK1157821A1 HK11111937.0A HK11111937A HK1157821A1 HK 1157821 A1 HK1157821 A1 HK 1157821A1 HK 11111937 A HK11111937 A HK 11111937A HK 1157821 A1 HK1157821 A1 HK 1157821A1
Authority
HK
Hong Kong
Prior art keywords
mesothelin
urinary
assessment
detection
ovarian cancer
Prior art date
Application number
HK11111937.0A
Other languages
English (en)
Inventor
Shannessy Daniel J O
Niranjan Y Sardesai
Jennifer Bones
Original Assignee
Fujirebio America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujirebio America Inc filed Critical Fujirebio America Inc
Publication of HK1157821A1 publication Critical patent/HK1157821A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
HK11111937.0A 2003-03-13 2011-11-04 -/ 檢測尿的間皮素/巨核細胞促進因子相關肽用於評估卵巢癌 HK1157821A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/388,930 US20040180387A1 (en) 2003-03-13 2003-03-13 Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of ovarian cancer

Publications (1)

Publication Number Publication Date
HK1157821A1 true HK1157821A1 (zh) 2012-07-06

Family

ID=32962160

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11111937.0A HK1157821A1 (zh) 2003-03-13 2011-11-04 -/ 檢測尿的間皮素/巨核細胞促進因子相關肽用於評估卵巢癌

Country Status (5)

Country Link
US (1) US20040180387A1 (zh)
EP (2) EP2316969B1 (zh)
JP (2) JP4722834B2 (zh)
HK (1) HK1157821A1 (zh)
WO (1) WO2004083449A2 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005072341A2 (en) * 2004-01-21 2005-08-11 Fujirebio America, Inc. Detection of mesothelin-/megakaryocyte potentiating factor-related peptides in peritoneal fluid for assessment of the peritoneum and the peritoneal cavity
US20060014221A1 (en) * 2004-01-21 2006-01-19 Fujirebio Diagnostics, Inc. Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of mesothelioma
WO2009108932A2 (en) * 2008-02-28 2009-09-03 The Johns Hopkins University Selectin ligands useful in the diagnosis and treatment of cancer
JP2010014691A (ja) * 2008-06-20 2010-01-21 Igaku Seibutsugaku Kenkyusho:Kk 腹水中のメソテリン及び／又は巨核球増強因子を検出するための方法、キット、試薬及び装置
US20120115244A1 (en) 2010-11-09 2012-05-10 Abbott Laboratories Materials and methods for immunoassay of pterins
KR20140014116A (ko) 2010-12-20 2014-02-05 제넨테크, 인크. 항-메소텔린 항체 및 면역접합체
CN103344761A (zh) * 2013-04-23 2013-10-09 深圳市柏明胜医疗器械有限公司 一种he4量子点标记的双夹心免疫分析检测试剂盒及其应用
AU2015326756A1 (en) * 2014-10-02 2017-05-11 Zora Biosciences Oy Methods for detecting ovarian cancer
CN106841190B (zh) * 2017-03-22 2020-07-24 西北师范大学 以TMB为显色剂的Ag+可视化检测方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
WO1987002671A1 (en) 1985-11-01 1987-05-07 International Genetic Engineering, Inc. Modular assembly of antibody genes, antibodies prepared thereby and use
US5139744A (en) * 1986-03-26 1992-08-18 Beckman Instruments, Inc. Automated laboratory work station having module identification means
US5225539A (en) * 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
DE68927933T2 (de) 1988-09-02 1997-08-14 Dyax Corp Herstellung und auswahl von rekombinantproteinen mit verschiedenen bindestellen
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
JPH06508511A (ja) 1990-07-10 1994-09-29 ケンブリッジ　アンティボディー　テクノロジー　リミティド 特異的な結合ペアーの構成員の製造方法
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
DK0554356T3 (da) * 1990-10-12 1999-06-14 Us Health Monoklonalt antistof
DE69129154T2 (de) 1990-12-03 1998-08-20 Genentech, Inc., South San Francisco, Calif. Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
EP0575485A1 (en) 1991-03-01 1993-12-29 Dyax Corp. Process for the development of binding mini-proteins
JP3672306B2 (ja) 1991-04-10 2005-07-20 ザ スクリップス リサーチ インスティテュート ファージミドを使用するヘテロ二量体受容体ライブラリー
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
JP3328341B2 (ja) * 1991-12-27 2002-09-24 中外製薬株式会社 新規な巨核球増幅因子
US5622835A (en) * 1994-04-28 1997-04-22 The Wistar Institute Of Anatomy & Biology WT1 monoclonal antibodies
JP2000505787A (ja) * 1996-01-05 2000-05-16 アメリカ合衆国 中皮抗原及びそれを標的化するための方法及びキット
WO2000050900A2 (en) 1999-02-26 2000-08-31 Pacific Northwest Research Institute Methods and compositions for diagnosing carcinomas
US6770445B1 (en) * 1999-02-26 2004-08-03 Pacific Northwest Research Institute Methods and compositions for diagnosing carcinomas
US20030087250A1 (en) * 2001-03-14 2003-05-08 Millennium Pharmaceuticals, Inc. Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer

Also Published As

Publication number Publication date
EP2316969B1 (en) 2015-12-16
EP1611250A4 (en) 2007-04-18
JP4722834B2 (ja) 2011-07-13
JP5570029B2 (ja) 2014-08-13
EP1611250B1 (en) 2012-12-19
EP2316969A1 (en) 2011-05-04
WO2004083449A2 (en) 2004-09-30
EP1611250A2 (en) 2006-01-04
WO2004083449A3 (en) 2005-09-15
JP2011174933A (ja) 2011-09-08
JP2007525643A (ja) 2007-09-06
US20040180387A1 (en) 2004-09-16

Similar Documents

Publication Publication Date Title
HK1157821A1 (zh) -/ 檢測尿的間皮素/巨核細胞促進因子相關肽用於評估卵巢癌
IL180601A0 (en) Methods and compositions for the detection of ovarian cancer
HK1231521A1 (zh) 癌症復發的可能性預測
EP1756566A4 (en) BIOMARKER FOR OVARIAL CARCINOMA
AU2002951346A0 (en) Diagnosis of ovarian cancer
EP1816953A4 (en) CANCER DETECTION AND TREATMENT INSTRUMENT
AU2002312347A1 (en) Detection of ovarian cancer based upon alpha-haptoglobin levels
TWI367326B (en) Wnt proteins and detection and treatment of cancer
HK1083443A1 (en) Thiazolidin-4-ones for inhibiting hyak3 proteins
HK1086573A1 (en) Quinazoline derivatives for treatment of cancer
GB0426982D0 (en) Early detection of sepsis
GB0303053D0 (en) Collusion detection
EP1805519A4 (en) WNT PROTEINS AND THE DETECTION AND TREATMENT OF CANCER
AU2003269618A8 (en) Methods for detecting breast and ovarian cancer
GB0525541D0 (en) Detection of antibodies
AU2003235749A8 (en) Biomarkers for detecting ovarian cancer
TWI318680B (en) Detection of macro-defects using micro-inspection inputs
AU2003213960A1 (en) Methods for detecting ovarian cancer
GB0320809D0 (en) Particle detection
EP1594989A4 (en) PROCESS FOR EARLY DIAGNOSIS OF EGG CANCER
EP1671645A4 (en) REMEDIES AND MEDIUM FOR DETECTING GALLENGIFT CANCER
EP1952143A4 (en) METHOD FOR DETECTING OVARIAL CARCINOMA
AU2003278211A8 (en) Methods for detection of genetic alterations associated with cancer
AU2003287564A1 (en) Methods of detecting colorectal cancer
EP1926836A4 (en) COMPOSITIONS AND METHODS FOR DETECTING COLORECTAL CARCINOMA

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20240314